Have a personal or library account? Click to login
Multiple sclerosis lesions on magnetic resonance imaging, their characterization and pathological correlation with musculoskeletal disability in Pakistanis Cover

Multiple sclerosis lesions on magnetic resonance imaging, their characterization and pathological correlation with musculoskeletal disability in Pakistanis

Open Access
|Mar 2017

References

  1. 1Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372:1502-17.1897097710.1016/S0140-6736(08)61620-7
    CompstonAColesAMultiple sclerosisLancet2008372150217
  2. 2Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001; 22:117-39.10.1007/s10072017001111603614
    RosatiGThe prevalence of multiple sclerosis in the world: an updateNeurol Sci20012211739
  3. 3Clanet M. Jean-Martin Charcot. 1825 to 1893. Int MS J. 2008; 15:59-61.18782501
    ClanetMJean-Martin Charcot. 1825 to 1893Int MS J2008155961
  4. 4Chari DM. Remyelination in multiple sclerosis. Int Rev Neurobiol. 2007; 79:589-620.10.1016/S0074-7742(07)79026-817531860
    ChariDMRemyelination in multiple sclerosisInt Rev Neurobiol200779589620
  5. 5Giorgio A, Stefano ND. Advanced structural and functional brain MRI in multiple sclerosis. Semin Neurol. 2016; 36:163-76.10.1055/s-0036-157973727116723
    GiorgioAStefanoNDAdvanced structural and functional brain MRI in multiple sclerosisSemin Neurol20163616376
  6. 6Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009; 132:1175-89.10.1093/brain/awp07019339255
    FrischerJMBramowSDal-BiancoALucchinettiCFRauschkaHSchmidbauerMThe relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain2009132117589
  7. 7CAMMS223 Trial Investigators, Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, et al. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 2008; 359:1786-801.1894606410.1056/NEJMoa0802670
    CAMMS223 Trial InvestigatorsColesAJCompstonDASelmajKWLakeSLMoranSAlemtuzumab vs. interferon beta-1a in early multiple sclerosisN Engl J Med20083591786801
  8. 8Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet. 1981; 2:1063-6.6118521
    YoungIRHallASPallisCALeggNJBydderGMSteinerRENuclear magnetic resonance imaging of the brain in multiple sclerosisLancet198121063610.1016/S0140-6736(81)91273-3
  9. 9Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol. 1994; 36 (Suppl):S6-11.10.1002/ana.4103607048017890
    WeinshenkerBGNatural history of multiple sclerosisAnn Neurol199436SupplS6118017890
  10. 10O’Riordan JI, Thompson AJ, Kingsley DP, MacManus DG, Kendall BE, Rudge P, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. 1998; 121:495-503.10.1093/brain/121.3.4959549525
    O’RiordanJIThompsonAJKingsleyDPMacManusDGKendallBERudgePThe prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-upBrain19981214955039549525
  11. 11McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50:121-7.10.1002/ana.1032
    McDonaldWICompstonAEdanGGoodkinDHartungHPLublinFDRecommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosisAnn Neurol200150121711456302
  12. 12Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005; 58:840-6.10.1002/ana.2070316283615
    PolmanCHReingoldSCEdanGFilippiMHartungHPKapposLDiagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Ann Neurol2005588406
  13. 13Polman CH1 Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69:292-302.10.1002/ana.2236621387374
    PolmanCHReingoldSCBanwellBClanetMCohenJAFilippiMDiagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaAnn Neurol201169292302
  14. 14Swanton JK, Fernando K, Dalton CM, Miszkiel KA, Thompson AJ, Plant GT, et al. Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison. J Neurol Neurosurg Psychiatry. 2006; 77:1070-2.10.1136/jnnp.2006.09091016788011
    SwantonJKFernandoKDaltonCMMiszkielKAThompsonAJPlantGTIs the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparisonJ Neurol Neurosurg Psychiatry20067710702
  15. 15Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol. 2003; 2:555-62.1294157810.1016/S1474-4422(03)00504-0
    LycklamaGThompsonAFilippiMMillerDPolmanCFazekasFSpinal-cord MRI in multiple sclerosisLancet Neurol2003255562
  16. 16Comi G, Filippi M, Barkhof F, Durelli L, Edan G, Fernandez O, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001; 357:1576-82.10.1016/S0140-6736(00)04725-511377645
    ComiGFilippiMBarkhofFDurelliLEdanGFernandezOEffect of early interferon treatment on conversion to definite multiple sclerosis: a randomised studyLancet2001357157682
  17. 17Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1962; 25:315-20.10.1136/jnnp.25.4.31514016083
    BrownellBHughesJTThe distribution of plaques in the cerebrum in multiple sclerosisJ Neurol Neurosurg Psychiatry19622531520
  18. 18Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol. 2008; 7:841-51.10.1016/S1474-4422(08)70191-118703006
    GeurtsJJBarkhofFGrey matter pathology in multiple sclerosisLancet Neurol2008784151
  19. 19Kuhlmann T1, Lingfeld G, Bitsch A, Schuchardt J, Brück W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain. 2002; 125:2202-12.10.1093/brain/awf23512244078
    KuhlmannT1LingfeldGBitschASchuchardtJBrückWAcute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over timeBrain200212522021212244078
  20. 20Kurtzke JF. On the evaluation of disability in multiple sclerosis. Neurology. 1961; 11:686.1375533510.1212/WNL.11.8.686
    KurtzkeJFOn the evaluation of disability in multiple sclerosisNeurology19611168613755335
  21. 21Freal J, Kraft G, Coryell J. Symptomatic fatigue in multiple sclerosis. Arch Physic Med Rehab. 1984; 65: 135-8.
    FrealJKraftGCoryellJSymptomatic fatigue in multiple sclerosisArch Physic Med Rehab1984651358
  22. 22Simonsen CS, Edland A, Berg-Hansen P, Celius EG. High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud. Acta Neurol Scand. 2016.27241360
    SimonsenCSEdlandABerg-HansenPCeliusEGHigh prevalence and increasing incidence of multiple sclerosis in the Norwegian county of BuskerudActa Neurol Scand201610.1111/ane.1261527241360
  23. 23Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006; 5:932-6.10.1016/S1474-4422(06)70581-6
    OrtonSMHerreraBMYeeIMValdarWRamagopalanSVSadovnickADSex ratio of multiple sclerosis in Canada: a longitudinal studyLancet Neurol200659326
  24. 24Swingler R, Compston DAS. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatr. 1986; 49:1115-24.10.1136/jnnp.49.10.1115
    SwinglerRCompstonDASThe distribution of multiple sclerosis in the United KingdomJ Neurol Neurosurg Psychiatr198649111524
  25. 25Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, et al. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. Mult Scler. 2013; 19: 1485-92.10.1177/135245851347867323462349
    MühlauMBuckDFörschlerABoucardCCArsicMSchmidtPWhite-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRIMult Scler201319148592
  26. 26Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, et al. Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. Am J Neuroradiol. 2014; 35:912-9.10.3174/ajnr.A3788
    CappellaniRBergslandNWeinstock-GuttmanBKennedyCCarlERamasamyDPSubcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI studyAm J Neuroradiol2014359129
  27. 27Filippi M, Rocca MA. MR imaging of multiple sclerosis. Radiol. 2011; 259:659-81.10.1148/radiol.11101362
    FilippiMRoccaMAMR imaging of multiple sclerosisRadiol201125965981
  28. 28Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol. 2006; 5:158-70.10.1016/S1474-4422(06)70349-016426992
    BermelRABakshiRThe measurement and clinical relevance of brain atrophy in multiple sclerosisLancet Neurol2006515870
  29. 29van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999; 46:747-54.10.1002/1531-8249(199911)46:5<;747::AID-ANA10>3.0.CO;2-410553992
    van WaesbergheJHKamphorstWDe GrootCJvan WalderveenMACastelijnsJARavidRAxonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disabilityAnn Neurol19994674754
  30. 30Al-Saeed O, Ismail M, Athyal RP, Rudwan M, Khafajee S. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions. J Med Imaging Radiat Oncol. 2009; 53: 366-72.1969504310.1111/j.1754-9485.2009.02093.x
    Al-SaeedOIsmailMAthyalRPRudwanMKhafajeeST1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesionsJ Med Imaging Radiat Oncol20095336672
  31. 31Bedell BJ, Narayana PA. Implementation and evaluation of a new pulse sequence for rapid acquisition of double inversion recovery images for simultaneous suppression of white matter and CSF. J Magn Reson Imaging. 1998; 8:544-7.10.1002/jmri.18800803059626866
    BedellBJNarayanaPAImplementation and evaluation of a new pulse sequence for rapid acquisition of double inversion recovery images for simultaneous suppression of white matter and CSFJ Magn Reson Imaging199885447
  32. 32Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain. 2002; 125:1676-95.10.1093/brain/awf17712135961
    MillerDHBarkhofFFrankJAParkerGJThompsonAJMeasurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevanceBrain2002125167695
  33. 33Swirsky-Sacchetti T, Mitchell DR, Seward J, Gonzales C, Lublin F, Knobler R, et al. Neuropsychological and structural brain lesions in multiple sclerosis a regional analysis. Neurol. 1992; 42:1291.10.1212/WNL.42.7.1291
    Swirsky-SacchettiTMitchellDRSewardJGonzalesCLublinFKnoblerRNeuropsychological and structural brain lesions in multiple sclerosis a regional analysisNeurol1992421291
  34. 34Honig L, Wasserstein P, Adornato B. Tonic spasms in multiple sclerosis; anatomic basis and treatment. West J Med. 1991; 154:723.1877214
    HonigLWassersteinPAdornatoBTonic spasms in multiple sclerosis; anatomic basis and treatmentWest J Med1991154723
  35. 35Zackowski KM, Smith SA, Reich DS, Gordon-Lipkin E, Chodkowski BA, Sambandan DR, et al. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain. 2009; 132:1200-9.10.1093/brain/awp03219297508
    ZackowskiKMSmithSAReichDSGordon-LipkinEChodkowskiBASambandanDRSensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cordBrain200913212009
  36. 36Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, et al. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain. 2007; 130:2211-9.10.1093/brain/awm11017535835
    AgostaFAbsintaMSormaniMPGhezziABertolottoAMontanariEIn vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI studyBrain200713022119
  37. 37Hartung HP, Will RG, Francis D, Grosse-Wilde H, Rudge P, Scaravilli F, et al. Familial multiple sclerosis. J Neurol Sci. 1988; 83:259-68.335699210.1016/0022-510X(88)90073-1
    HartungHPWillRGFrancisDGrosse-WildeHRudgePScaravilliFFamilial multiple sclerosisJ Neurol Sci19888325968
  38. 38Madden DJ, Spaniol J, Costello MC, Bucur B, White LE, Cabeza R, et al. Cerebral white matter integrity mediates adult age differences in cognitive performance. J Cogn Neurosci. 2009; 21:289-302.10.1162/jocn.2009.2104718564054
    MaddenDJSpaniolJCostelloMCBucurBWhiteLECabezaRCerebral white matter integrity mediates adult age differences in cognitive performanceJ Cogn Neurosci200921289302267633618564054
  39. 39Bunce D, Handley R, Gaines SO. Depression, anxiety, and within-person variability in adults aged 18 to 85 years. Psychol Aging. 2008; 23:848-58.10.1037/a001367819140655
    BunceDHandleyRGainesSODepression, anxiety, and within-person variability in adults aged 18 to 85 yearsPsychol Aging2008238485819140655
  40. 40Bjornevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, et al. Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study. Mult Scler. 2016; 5. [Epub ahead of print]
    BjornevikKRiiseTBenjaminsenECeliusEGDahlOPKampmanMTLevel of education and multiple sclerosis risk over a 50-year period: Registry-based sibling studyMult Scler20165[Epub ahead of print]10.1177/1352458516646863530207627207453
DOI: https://doi.org/10.5372/1905-7415.1006.526 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 567 - 574
Published on: Mar 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2017 Nasir Raza Zaidi, Mian Waheed Ahmad, Riffat Mehboob, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.